Forus vs Infinitus Systems
Two attacks on the same obstacle, getting a prescribed medication actually into a patient's hands, from different ends of the process. Forus sits at the point of prescribing and automates the paperwork path: generating and submitting the prior authorization, drafting appeals, routing to pharmacy, verifying benefits and finding affordability programmes, and it is free to the provider. Infinitus automates the phone call that the paperwork path cannot avoid, dialling the payer, holding, and extracting benefits and authorisation status from a representative, then writing the result back as structured data. They are complementary more than competitive. The question worth asking Forus first is who pays for it, because a free platform that routes prescriptions has an economic relationship somewhere, and the answer changes how you read its coverage claims.
- The price to the provider is published and it is zero, stated without a trial qualifier, which is a commercial fact worth establishing before comparing anything else.
- The system acts rather than recommends: it completes and submits authorisation forms and drafts appeals, embedded at the point of prescribing, with coverage stated as any drug, any insurance, any pharmacy.
- It states plainly that all protected health information is covered under a business associate agreement, alongside SOC 2 Type 2 with the meaningful type named.
- It automates the payer phone call, which is the part of medication access that no form submission reaches: benefit verification and authorisation status obtained by an agent that dials, waits and speaks to a representative.
- Call outcomes are written back as structured data rather than left in a transcript, and the architecture is described concretely as a knowledge graph of payer specific rules.
- Coverage spans both workflow types and customer classes rather than the medication path alone, so the same agent handles benefit verification across therapeutic areas.
Side by Side
| Axis | F Forus |
I Infinitus Systems |
|---|---|---|
| AI Centrality | ||
| Autonomy and Oversight Model | ||
| Model and Technology Transparency | ||
| Clinical and Operational Evidence | ||
| AI Safety and PHI Stewardship | ||
| HIPAA and BAA Posture | ||
| Security Certifications and Trust Center | ||
| FDA and Regulatory Status | ||
| AI Governance and Bias Disclosure | ||
| EHR and Interoperability Depth | ||
| Deployment Model and Data Residency | ||
| Commercial Transparency | ||
| Setting and Specialty Coverage |
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the RCM & Prior Auth AI page.
A product that is free to the provider is being paid for by someone else, and in medication access that is usually a pharmaceutical manufacturer or a pharmacy channel; establish who pays and what they receive, because a platform routing prescriptions has a commercial interest in where they land. Neither vendor publishes a governance framework, bias evaluation or subgroup performance analysis. Infinitus publishes no hosting, residency or subprocessor detail.
Both automate steps that determine whether a patient gets a medication, and neither publishes what happens when the automation is wrong or how a patient learns that an authorisation was denied by a process nobody in the practice ran.